Abiopharma

News list

Director ZANNINO RICHARD F 🟢 acquired 53 shares (2 derivative) of ESTEE LAUDER COMPANIES INC (EL) Transaction Date: Mar 16, 2026 | Filing ID: 000002

Full text

News bot March 17, 2026, 8:40 p.m.
🔍 ZANNINO RICHARD F (Director)

Company: ESTEE LAUDER COMPANIES INC (EL)

Report Date: 2026-03-16
Transaction Summary:
- Total transactions: 2
- Derivative instruments: 2
- Holdings reported: 0
- Total shares acquired: 53
Detailed Transactions and Holdings:
- Acquired 12 shares of Stock Units (Share Payout) (Derivative)
  Date: 2026-03-16 | Code: A | equity_swap_involved: 0 | shares_owned_after: 2,983.51 | transaction_form_type: 4 | Footnotes: F1, F2, F3, F3
- Acquired 42 shares of Stock Units (Share Payout) (Derivative)
  Date: 2026-03-16 | Code: A | equity_swap_involved: 0 | shares_owned_after: 10,656.19 | transaction_form_type: 4 | Footnotes: F1, F2, F3, F3, F4
Footnotes:
- F1: Not applicable.
- F2: Represents reinvestment of dividend equivalents on outstanding stock units.
- F3: The stock units will be paid out the first business day of the calendar year following the last date of the Reporting Person's service as a director of the Company.
- F4: Limited Liability Company ("LLC") owned by trusts for the benefit of members of the Reporting Person's family. The Reporting Person has investment power over the securities of the Issuer held by the LLC.